{
  "meta": {
    "title": "Paroxysmal_Nocturnal_Hemoglobinuria",
    "url": "https://brainandscalpel.vercel.app/paroxysmal-nocturnal-hemoglobinuria-d81f2411.html",
    "scrapedAt": "2025-11-29T18:32:06.427Z"
  },
  "questions": [
    {
      "id": 14303,
      "choices": [
        {
          "id": 57173,
          "text": "<p><span style=\"font-size:12pt;\">Spectrin</span></p>"
        },
        {
          "id": 57174,
          "text": "<p><span style=\"font-size:12pt;\">Defect in complement activating proteins</span></p>"
        },
        {
          "id": 57175,
          "text": "<p><span style=\"font-size:12pt;\">Defective GPI anchor</span></p>"
        },
        {
          "id": 57176,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannose-binding residue effect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 30-year-old male presents with dark urine in the morning and has been found to have hemolytic anemia on laboratory evaluation. A diagnostic test reveals increased sensitivity of his red blood cells to lysis in acidified serum. Which of the following underlying defects is most consistent with these findings?</span></p>",
      "unique_key": "Q6543400",
      "question_audio": null,
      "question_video": null,
      "map_id": 31940,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Defective GPI anchor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ham’s acidified </strong>serum test is used for the diagnosis of <strong>paroxysmal nocturnal hemoglobinuria (PNH). </strong>In this condition, <strong>defective GPI anchor </strong>prevents the attachment of <strong>CD55, CD59 and C8 binding protein</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A <strong>defective GPI (glycosylphosphatidylinositol) </strong>anchor leads to<strong> paroxysmal nocturnal hemoglobinuria (PNH) </strong>by failing to secure protective proteins such as<strong> CD55 and CD59 to the cell membrane</strong>, leaving<strong> red blood cells </strong>susceptible to<strong> complement-mediated lysis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Spectrin is a cytoskeletal protein</strong> that helps maintain the<strong> red blood cell's shape</strong>. Defects in spectrin can cause <strong>hereditary spherocytosis </strong>but are not associated with increased red cell lysis in acidified serum.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B.</strong> <strong>Defect in complement activating proteins:</strong> PNH is due to complement regulatory (inhibitory) proteins not because of complement activating proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. The Mannose-binding lectin</strong> pathway is involved in <strong>innate immunity </strong>and can lead to<strong> opsonization and phagocytosis </strong>of pathogens, but defects here do not lead to the clinical picture described.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A<strong> defective GPI anchor </strong>is implicated in<strong> paroxysmal nocturnal hemoglobinuria (PNH), </strong>a condition that can be diagnosed with the <strong>Ham test</strong>, indicating <strong>increased red blood cell lysis </strong>in acidified serum due to<strong> increased complement sensitivity.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 645</strong></span></p>",
      "correct_choice_id": 57175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14269,
      "choices": [
        {
          "id": 57037,
          "text": "<p><span style=\"font-size:12pt;\">Thrombosis</span></p>"
        },
        {
          "id": 57038,
          "text": "<p><span style=\"font-size:12pt;\">Leukemia</span></p>"
        },
        {
          "id": 57039,
          "text": "<p><span style=\"font-size:12pt;\">Aplastic anemia</span>​​​​​</p>"
        },
        {
          "id": 57040,
          "text": "<p><span style=\"font-size:12pt;\">Hemolysis</span>​​​​​</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is NOT a clinical presentation feature of paroxysmal nocturnal hemoglobinuria?</span></p>",
      "unique_key": "Q3645182",
      "question_audio": null,
      "question_video": null,
      "map_id": 31939,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The<strong> triad of pancytopenia</strong>,<strong> thrombosis and hemolytic anemia is characteristic of PNH.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Aplastic anemia </strong>can be a presenting feature <strong>(as per Wintrobes, Hematology). </strong>We need to remem¬ber that <strong>PNH</strong> may progress to <strong>leukemia </strong>(leukaemia CAN be a complication and NOT a feature).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While patients with <strong>PNH </strong>may have an<strong> increased risk of developing leukemia, </strong>it is not a defining feature of <strong>PNH </strong>but rather a potential late complication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Thrombosis,</strong> particularly in unusual sites such as the <strong>hepatic or cerebral veins</strong>, is a well-recognized complication <strong>of paroxysmal nocturnal hemoglobinuria (PNH)</strong> due to the<strong> increased propensity for red blood cells </strong>to activate the <strong>complement system and the coagulation cascade</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Aplastic anemia</strong> can be a presenting feature of<strong> PNH due to the associated bone marrow failure </strong>that can occur with the disease process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Intravascular hemolysis</strong> is a<strong> hallmark of PNH</strong>, caused by the <strong>increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins </strong>that normally protect the <strong>cell membrane from complement activation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>PNH </strong>is characterized by<strong> hemolytic anemia, pancytopenia, and thrombosis</strong>, but<strong> leukemia is not a feature of PNH </strong>but may be a <strong>secondary complication </strong>of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10th/e p648</strong></span></p>",
      "correct_choice_id": 57038,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14309,
      "choices": [
        {
          "id": 57197,
          "text": "<p><span style=\"font-size:12pt;\">LDH levels are raised</span></p>"
        },
        {
          "id": 57198,
          "text": "<p><span style=\"font-size:12pt;\">Increased hemosiderin in urine</span></p>"
        },
        {
          "id": 57199,
          "text": "<p><span style=\"font-size:12pt;\">Decreased leukocyte alkaline phosphatase</span></p>"
        },
        {
          "id": 57200,
          "text": "<p><span style=\"font-size:12pt;\">Increased platelets</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 40-year-old patient presents with fatigue, episodes of dark urine, especially in the morning, and a recent history of thrombosis. Lab tests show hemolytic anemia and cytopenias. Which of the following findings is least likely to be associated with the likely diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)?</span></p>",
      "unique_key": "Q6817225",
      "question_audio": null,
      "question_video": null,
      "map_id": 31938,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Increased platelets</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Paroxysmal nocturnal hemoglobinuria (PNH) </strong>is a rare acquired disorder characterized by <strong>hemolysis, thrombosis, and bone marrow failure</strong>. Let's go through each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Increased platelets:</strong> <strong>False</strong>.<strong> PNH </strong>is associated with a <strong>decreased platelet count</strong>, not an increased one. <strong>Thrombocytopenia </strong>is a common feature due to <strong>increased platelet consumption and intravascular thrombosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. LDH levels are raised:</strong> <strong>True </strong>as<strong> LDH (lactate dehydrogenase) </strong>levels are often <strong>elevated in PNH </strong>due to<strong> intravascular hemolysis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Increased hemosiderin in urine:</strong> <strong>True</strong>; Hemolysis in<strong> PNH </strong>can result in the release of<strong> free hemoglobin</strong>, which is filtered by the <strong>kidneys</strong>, leading to<strong> hemosiderinuria.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Decreased leukocyte alkaline phosphatase:</strong> <strong>True; PNH cells </strong>are deficient in <strong>GPI-linked proteins, </strong>including <strong>alkaline phosphatase</strong>. Therefore,<strong> leukocyte alkaline phosphatase </strong>is <strong>decreased in PNH</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Thrombocytopenia</strong>, not thrombocytosis, is a <strong>common feature of PNH </strong>due to<strong> increased platelet consumption and intravascular thrombosis</strong>, leading to a <strong>decreased platelet count</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is classic for paroxysmal nocturnal hemoglobinuria (PNH):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Acquired clonal stem cell disorder → deficiency of GPI-anchored proteins (CD55, CD59)</span></li><li><span style=\"font-size:12.0pt;\">Complement-mediated intravascular hemolysis</span></li><li><span style=\"font-size:12.0pt;\">Thrombosis is a major cause of morbidity/mortality (often in unusual sites like hepatic veins)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 645</strong></span></p>",
      "correct_choice_id": 57200,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}